C Reactive Protein Testing Market Overview, Segmentation and Forecast to 2032
The C Reactive Protein Testing Market is positioned for sustained expansion as diagnostic testing becomes increasingly important in chronic disease management and preventive healthcare. According to MRFR, the market is expected to rise from USD 3.417 billion in 2025 to USD 6.66 billion by 2035, reflecting a 6.9% CAGR.
Increasing investment in advanced diagnostic technologies is supporting market development. High-sensitivity assays, automated laboratory platforms, and point-of-care devices are helping improve testing efficiency and accessibility. The growing availability of rapid diagnostic solutions may further encourage healthcare providers to incorporate CRP measurements into broader health assessments and disease-monitoring programs.
The market is segmented according to assay type and application. CLIA currently accounts for the largest assay segment, while ELISA is witnessing strong growth. Cardiovascular disease is the leading application, followed by areas such as diabetes, rheumatoid arthritis, and inflammatory bowel disease. The increasing focus on inflammatory biomarkers is expected to support demand across these clinical applications.
North America holds the largest regional position, whereas Asia-Pacific presents strong future growth prospects. Market opportunities are emerging from portable testing, home-based diagnostics, AI-supported analysis, and expansion into underserved healthcare markets. Continued technological innovation and increasing awareness of inflammation-related diseases are expected to remain important factors supporting the market through 2035.
Access detailed findings to navigate market complexities:
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Spellen
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness